Status:

COMPLETED

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

Lead Sponsor:

Emalex Biosciences Inc.

Collaborating Sponsors:

Psyadon Pharma

Conditions:

Pathological Gambling

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This study is designed to test the hypothesis that ecopipam is able to reduce urges to gamble in patients diagnosed with Pathological Gambling.

Detailed Description

The purpose of this study is to determine if ecopipam is able to stop urges to gamble in patients diagnosed with Pathological Gambling. Nerves communicate with each other by releasing chemicals called...

Eligibility Criteria

Inclusion

  • Subject must be diagnosed with Pathological Gambling according to DSMIV criteria
  • Subject must have at least 2 episodes of gambling behavior within the previous 2 weeks before screening
  • Subject must have gambling urges of at least moderate intensity

Exclusion

  • Subjects must not have unstable medical illness or clinically significant abnormalities on lab tests, ECG, or physical exam
  • Subjects with major depressive episode within the last 2 years
  • Subjects with a history of attempted suicide
  • Subjects with first degree relative with major depressive episode that resulted in hospitalization, attempted or completed suicide
  • Subjects with a history of epilepsy or seizures
  • Subjects with a myocardial infarction (heart attack) with in the last 6 months
  • Subjects with a lifetime history of bipolar disorder, dementia, schizophrenia, or any psychotic disorder
  • Subjects with current of recent DSM-IV diagnosis of substance abuse or dependence (with the exception of nicotine)

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT01215357

Start Date

October 1 2010

End Date

August 1 2012

Last Update

May 14 2024

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University of California, Los Angeles

Los Angeles, California, United States, 90095

2

Yale University

New Haven, Connecticut, United States, 06519

3

Carver College of Medicine, University of Iowa

Iowa City, Iowa, United States, 52242

4

University of Minnesota School of Medicine

Minneapolis, Minnesota, United States, 55454

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble | DecenTrialz